Gene Therapy for Parkinson's and Alzheimer's Diseases: from the Bench to Clinical Trials

Publisher： Bentham Science Publishers

E-ISSN： 1873-4286|17|31|3434-3445

ISSN： 1381-6128

Source： Current Pharmaceutical Design, Vol.17, Iss.31, 2011-10, pp. : 3434-3445

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Tirapazamine: From Bench to Clinical Trials

By  

Current Clinical Pharmacology, Vol. 1, Iss. 1, 2006-01 ,pp. : 71-79

Bentham Science Publishers

Access to resources Recommend Favorite

CDK Inhibitors: From the Bench to Clinical Trials

By  

Current Drug Targets, Vol. 11, Iss. 3, 2010-03 ,pp. : 279-290

Bentham Science Publishers

Access to resources Recommend Favorite

Creutzfeldt-Jakob, Parkinson, Lewy Body Dementia and Alzheimer Diseases: From Diagnosis to Therapy

By  

Central Nervous System Agents in Medicinal Chemistry (Formerly Current Medicinal Chemistry - Central Nervous System Agents), Vol. 9, Iss. 1, 2009-03 ,pp. : 2-11

Bentham Science Publishers

Access to resources Recommend Favorite

Electroporation Gene Therapy Preclinical and Clinical Trials for Melanoma

By  

Current Gene Therapy, Vol. 10, Iss. 4, 2010-08 ,pp. : 312-317

Bentham Science Publishers

Access to resources Recommend Favorite

Neuroprotective Effects of Fisetin in Alzheimer’s and Parkinson’s Diseases: From Chemistry to Medicine

By  

Current Topics in Medicinal Chemistry, Vol. 16, Iss. 17, 2016-07 ,pp. : 1910-1915

Bentham Science Publishers

Access to resources Recommend Favorite